So this isn't purely a one sided benefit to Admedus (with speculation of a possible tie down the road) but more like an extremely lucky find for Genzyme who scored the perfect longterm tenant for there building which inturn saved them having to move or layoff existing staff. Thanks for the insight Caketin, much appreciated.
- Forums
- ASX - By Stock
- The Shed
So this isn't purely a one sided benefit to Admedus (with...
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.25 |
Change
0.000(0.00%) |
Mkt cap ! $301.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $15.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.55 | 111 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 15.000 |
1 | 64 | 14.990 |
1 | 1000 | 14.500 |
2 | 990 | 14.250 |
1 | 499 | 14.150 |
Price($) | Vol. | No. |
---|---|---|
14.550 | 111 | 2 |
15.150 | 149 | 1 |
15.500 | 44 | 1 |
15.700 | 277 | 1 |
15.880 | 250 | 1 |
Last trade - 09.50am 13/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online